• Arkeh Capital
    ... Price increases for graphite electrodes (SGL 9%, BAM 8%) will stick.
    11/8/12
    Reply (9)
    • Arkeh Capital: Price increases were announced with the Ambition to recover margin.
      11/8/12
    • Arkeh Capital: BAM: Background: needle coke accounts for 40-45% of productions costs for electrodes.
      11/8/12
    • Arkeh Capital: BAM: SGL saying Q1 volume Outlook not looking too bad (in Response to question whether Price increase announcement and good Q4 bookings ...
      11/8/12
    • Arkeh Capital: ... to result in Q1 drop in volumes)
      11/8/12
    • Arkeh Capital: My take is that Price increases may probably not be defendable, but falling needle coke Prices would help margins.
      11/8/12
    • Arkeh Capital: Please note that BAM has cut H2 production to sell down inventory / production time for a graphite electrode is several weeks. If GTI and ..
      11/8/12
    • Arkeh Capital: SGL run down inventory as production now would be on higher needle coke, there is a good Chance for Price stability or slight increases ...
      11/8/12
    • Arkeh Capital: despite lower costs. Note that Q1 2012 volumes at BAM were extremely weak due to Price increase in Q1 and Clients buying in Q4 2010.
      11/8/12
    • Arkeh Capital: Easy comparable in 2013 and artificially depressed sales and Profit this year.
      11/8/12